Cargando…
Delayed Hypersensitivity Reactions Following First Dose of the SARS-CoV2 mRNA Vaccines
Autores principales: | Xu, Jennifer, Vanijcharoenkarn, Kristine, Sexton, Mary Elizabeth, Martin, Lindsay, Lee, Frances Eun-Hyung, Kuruvilla, Merin Elizabeth |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer International Publishing
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8294276/ https://www.ncbi.nlm.nih.gov/pubmed/34291376 http://dx.doi.org/10.1007/s11606-021-07015-w |
Ejemplares similares
-
Immediate Reactions After the First Dose of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Messenger RNA Vaccines Do Not Preclude Second-Dose Administration
por: Vanijcharoenkarn, Kristine, et al.
Publicado: (2021) -
The Role of Mast Cells in Aspirin-Exacerbated Respiratory Disease (AERD) Pathogenesis: Implications for Future Therapeutics
por: Kuruvilla, Merin E, et al.
Publicado: (2020) -
COVID-19 VACCINE ADMINISTRATION IN PATIENTS WITH FIRST-DOSE ADVERSE REACTIONS OR HISTORY OF SEVERE ALLERGIC REACTION
por: Vanijcharoenkarn, K., et al.
Publicado: (2022) -
Serum Levels of Hypersensitive-C-Reactive Protein in Vitiligo
por: Namazi, M. R., et al.
Publicado: (2018) -
Sorafenib Induced Hand-Foot Skin Reaction at Low Dose
por: Shah, Vrutika H., et al.
Publicado: (2020)